Quality improvement in neurology: Parkinson disease update quality measurement set

Approximately 630,000 people in the United States carried a diagnosis of Parkinson disease (PD) in 2010, and worldwide estimates indicate that up to 10 million individuals may be diagnosed currently.1,2 The national economic burden of PD was estimated to exceed $14.4 billion in 2010.1 PD is a heterogeneous disorder with motor and nonmotor features that are often underdiagnosed and, in turn, provided limited treatment options. The American Academy of Neurology (AAN) created a quality measurement set in 2010 to provide a framework for measuring progress on addressing these treatment gaps in care.3

[1]  J. Markowitz,et al.  Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. , 2000, The American journal of psychiatry.

[2]  W. Weiner,et al.  Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2006, Neurology.

[3]  E. Cheng,et al.  The quality of care delivered to Parkinson's disease patients in the U.S. Pacific Northwest Veterans Health System , 2006, BMC neurology.

[4]  W. Poewe,et al.  Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2006, Neurology.

[5]  K. Dujardin,et al.  Anxiety rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[6]  Christopher T. Bever,et al.  Quality improvement in neurology: AAN Parkinson disease quality measures Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology , 2010 .

[7]  A. Lang,et al.  Impulse control disorders in parkinson disease: A multicenter case–control study , 2011, Annals of neurology.

[8]  S. Lewis,et al.  Parkinson’s disease in general practice: Assessing knowledge, confidence and the potential role of education , 2011, Journal of Clinical Neuroscience.

[9]  G. Ransmayr.  Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson’s disease , 2011, Journal of Neural Transmission.

[10]  S. Reich,et al.  Quality Improvement in Neurology: AAN Parkinson Disease Quality Measures , 2011, Neurology.

[11]  M. Schenkman,et al.  Exercise for People in Early- or Mid-Stage Parkinson Disease: A 16-Month Randomized Controlled Trial , 2012, Physical Therapy.

[12]  F. Stocchi,et al.  Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease , 2012, European journal of neurology.

[13]  B. Robottom.  Neurologist care in Parkinson disease: A utilization, outcomes, and survival study , 2012 .

[14]  Victoria A Goodwin,et al.  An exercise intervention to prevent falls in Parkinson’s: an economic evaluation , 2012, BMC Health Services Research.

[15]  T. Dall,et al.  The current and projected economic burden of Parkinson's disease in the United States , 2013, Movement disorders : official journal of the Movement Disorder Society.

[16]  R. Walker,et al.  Palliative care in people with idiopathic Parkinson's disease who die in hospital , 2013, BMJ Supportive & Palliative Care.

[17]  K. Poon,et al.  Quality Care Assessment of Parkinson's Disease at a Tertiary Medical Center , 2013, The International journal of neuroscience.

[18]  H. Shill,et al.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease , 2014, Neurology.

[19]  T. Simuni,et al.  Back to the basics: regular exercise matters in parkinson's disease: results from the National Parkinson Foundation QII registry study. , 2014, Parkinsonism & related disorders.

[20]  B. Bloem,et al.  Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's disease. , 2014, Parkinsonism & related disorders.

[21]  Matthew Rizzo,et al.  Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting , 2014, Neurology.

[22]  Bastiaan R Bloem,et al.  Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial , 2014, The Lancet Neurology.

[23]  Natalie E. Allen,et al.  Exercise for falls prevention in Parkinson disease , 2015, Neurology.

[24]  M. Narayanasamy,et al.  A survey of older peoples' attitudes towards advance care planning. , 2015, Age and ageing.

[25]  Robert A. Gross,et al.  Spotlight on the January 6 Issue , 2015, Neurology.

[26]  N. Bagheri,et al.  Does it matter who organises your health care? , 2015, International journal of integrated care.

[27]  Amy E. Sanders,et al.  Quality improvement in neurology: Multiple sclerosis quality measures , 2015, Neurology.

[28]  S. Thilarajah,et al.  Effectiveness of resistance training on muscle strength and physical function in people with Parkinson’s disease: a systematic review and meta-analysis , 2016, Clinical rehabilitation.

[29]  D. Seidenwurm,et al.  Quality improvement in neurology Primary headache quality measures , 2022 .